Intermediate (Burkitt-Like) Lymphoma
1 clinical trials · Condition
◉ Watch Intermediate (Burkitt-Like) Lymphoma
| Record | Firm | Date |
|---|---|---|
| Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement. (NCT01854372) | The University of Texas Health Science Center at San Antonio | 2013-06-01 |
Track Intermediate (Burkitt-Like) Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.